for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AstraZeneca, Russia's Sputnik V developer to sign cooperation memorandum -Kremlin

MOSCOW, Dec 21 (Reuters) - Britain’s AstraZeneca and Russia’s Gamaleya Institute, which developed the Sputnik V vaccine, will sign a memorandum of intent on cooperation on Monday, the Kremlin said.

Russia’s RDIF sovereign wealth fund said this month AstraZeneca would start clinical trials to test a combination of its experimental COVID-19 vaccine with the Sputnik V shot to see if this can boost the efficacy of the British drugmaker’s vaccine. (Reporting by Dmitry Antonov; writing by Tom Balmforth; Editing by Hugh Lawson)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up